SCHEMBL15958624

SCHEMBL15958624

COc1nc2ccccc2nc1C#Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.48
KCNH2 Q12809 1/20 0.48
EGFR P00533 1/20 0.46
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
ADORA2A P29274 1/20 0.44
HDAC6 Q9UBN7 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
APP P05067 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HRH4 Q9H3N8 1/20 0.40
NQO2 P16083 2/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 3/20 0.39
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15958626 0.89 APP (0.46) GRM5KCNH2L3MBTL1APPMEN1
SCHEMBL15958661 0.85 GRM5 (0.51) GRM5KCNH2CYP1A2CYP2D6CYP2C9
SCHEMBL12669915 0.82 ADORA2A (0.41) GRM5KCNH2EGFRPDGFRBPDGFRA
SCHEMBL13595046 0.82 KDM4E (0.45) EGFRADORA2AL3MBTL1MEN1KMT2A
SCHEMBL12669918 0.76 CYP1A2 (0.44) GRM5KCNH2ADORA2AL3MBTL1APP
SCHEMBL13595053 0.76 NPC1 (0.42) KCNH2L3MBTL1APPMEN1KMT2A
SCHEMBL30829266 0.75 ADORA2A (0.38) GRM5KCNH2EGFRPDGFRBPDGFRA
SCHEMBL7474377 0.74 NQO2 (0.56) HDAC6L3MBTL1MEN1KMT2AHRH4
SCHEMBL6934550 0.73 MAPT (0.52) GRM5KCNH2ADORA2AHDAC6L3MBTL1
SCHEMBL29187243 0.72 ADORA2A (0.35) GRM5KCNH2EGFRADORA2AAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809264-B2 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2014-08-19 US disclosed